Lexicon Pharmaceuticals Inc (LXRX) stock news · rev $49.8M
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
This LXRX news page leads with what Lexicon Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for LXRX yet. We will not pad this page with generic market recap.
Latest reported LXRX revenue for 2025-12-31 was $49.8M. Net income was -$50.3M. Revenue was up 60.2% from 2024-12-31 to 2025-12-31. LXRX currently screens at market cap $327.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LXRX stock page; for the tape open the quote page.
LXRX stock news FAQ
What are LXRX's latest revenue and net income?
Latest cached Lexicon Pharmaceuticals Inc (LXRX) revenue for Dec 31, 2025 was $49.8M. Net income was -$50.3M. Statements: https://lician.com/financials/lxrx
How did LXRX revenue change from the prior cached period?
Cached Lexicon Pharmaceuticals Inc (LXRX) revenue was up 60.2% from $31.1M (Dec 31, 2024) to $49.8M (Dec 31, 2025). Statements: https://lician.com/financials/lxrx
What is LXRX's market cap?
Lexicon Pharmaceuticals Inc (LXRX) market cap is $327.2M on the latest cached fundamentals snapshot.
What kind of company is LXRX?
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Where is LXRX stock news listed?
Cached stock news for Lexicon Pharmaceuticals Inc (LXRX) is listed at https://lician.com/news/lxrx. Filings: https://lician.com/sec/lxrx
Not investment advice.